ARGX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

argenx SE (ARGX) Earnings Date & Reports

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ARGX is expected to report earnings to rise 17.05% to $3.02 per share on July 31

Q2'25

Est.

$3.02

Q1'25

Beat

by $0.34

Q4'24

Beat

by $10.57

Q3'24

Beat

by $1.24

Q2'24

Beat

by $1.35

The last earnings report on May 08 showed earnings per share of $2.58, beating the estimate of $2.24. With 708.10K shares outstanding, the current market capitalization sits at 37.81B.

View a ticker or compare two or three

Compare

ARGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARGX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARGX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

Laarderhoogtweg 25

Phone

+31 107038441

Employees

1148

Web

https://www.argenx.com